129716-58-1
Chemical Structure
Dofequidar
Synonym(s): MS-209 free base
- CAS No.: 129716-58-1
- Formula:C30H31N3O3
- Molecular Weight:481.59
IUPAC Name: 1-(4-(2-hydroxy-3-(quinolin-5-yloxy)propyl)piperazin-1-yl)-2,2-diphenylethan-1-one
InChIKey: KLWUUPVJTLHYIM-UHFFFAOYSA-N
SMILES: OC(COC1=C2C=CC=NC2=CC=C1)CN3CCN(C(C(C4=CC=CC=C4)C5=CC=CC=C5)=O)CC3
Biological Activity: Dofequidar (MS-209 free base) is an orally active quinoline compoundthat blocks P-glycoprotein (P-gp) and multidrug resistance-associated protein-1 (MDR-1). Dofequidar has highly potent reversing effect on multidrug-resistant tumor cells. Dofequidar competitively inhibits ABCB1/P-gp, ABCC1/MRP-1, blocks the efflux of chemotherapeutic agents, increases the drug concentration in cancer cells, and enhances the chemotherapeutic effect[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Dofequidar | 99.29% | Dofequidar (MS-209 free base) is an orally active quinoline compoundthat blocks P-glycoprotein (P-gp) and multidrug resistance-associated protein-1 (MDR-1). Dofequidar has highly potent reversing effect on multidrug-resistant tumor cells. Dofequidar competitively inhibits ABCB1/P-gp, ABCC1/MRP-1, blocks the efflux of chemotherapeutic agents, increases the drug concentration in cancer cells, and enhances the chemotherapeutic effect. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.89
HY-17013ARDofequidar fumarate (Standard) -
Similarity Score 0.66
HY-19666RDPI 201-106 (Standard) -
Similarity Score 0.65
HY-129698MS-073 -
Similarity Score 0.59
HY-15255Zosuquidar -
Similarity Score 0.58
HY-50671Zosuquidar trihydrochloride -
Similarity Score 0.57
HY-116119BDF 9148 -
Similarity Score 0.56
HY-107384ARAsimadoline hydrochloride (Standard) -
Similarity Score 0.55
HY-107384Asimadoline -
Similarity Score 0.54
HY-120514JNc-440 -
Explore the MedChemAI to find more analogs
References
- [1]. Nokihara H, et al. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells. Jpn J Cancer Res. 2001 Jul;92(7):785-92. [Content Brief]
- [2]. Katayama R, et al. Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export. Cancer Sci. 2009 Nov;100(11):2060-8. [Content Brief]
